Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains

Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains

Increased severity of diseases caused by Coxsackievirus A10 (CV-A10) as well as a large number of mutants and recombinants circulating in the population are a cause of concern for public health. A vaccine with broad-spectrum and homogenous protective capacity is needed to prevent outbreaks of CV-A10...

Full description

Bibliographic Details
Main Authors: Yaqian Huo, Jinghuan Yang, Pei Liu, Bopei Cui, Chenfei Wang, Siyuan Liu, Fangyu Dong, Xujia Yan, Lianlian Bian, Fan Gao, Xing Wu, Jiuyue Zhou, Tong Cheng, Xiuling Li, Qunying Mao, Zhenglun Liang
Format: Article
Language:English
Published: Taylor & Francis Group 2021-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
coxsackievirus a10
cross-neutralization
cross-protection
hand, foot, and mouth disease (hfmd)
vaccine candidate
Online Access:http://dx.doi.org/10.1080/21645515.2021.1978792

Internet

http://dx.doi.org/10.1080/21645515.2021.1978792

Similar Items